ESMO Preceptorship on Immuno-Oncology 2023 Zurich

ESMO Preceptorship on Immuno-Oncology 2023 Zurich

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

European Society for Medical Oncology Preceptorship on Immuno-Oncology 2023 Zurich

Format: 19 videos + 21 pdfs, size: 2.04 GB

Course Audience: oncologist, immunologist

Overview:

Start date: 29 Sep 2023

End date: 30 Sep 2023

Location: Zurich, Switzerland

Learning objectives

  • To understand the basics of tumour immunology
  • To learn about the essentials of immunotherapies and their applications in cancer medicine
  • To learn about the status of development and clinical experience of immunotherapy in different tumour type

 

ESMO-Preceptorship-on-Immuno-Oncology-2023-Zurich-Programme (PDF Format)

Session 1 Adjuvant vs neoadjuvant (Video MP4 Format)

Session 1 Adjuvant vs neoadjuvant (PDF Format)

Session 1 Basic tumour immunology for oncologists (Video MP4 Format)

Session 1 Basic tumour immunology for oncologists (PDF Format)

Session 1 Biomarkers for immunotherapy (Video MP4 Format)

Session 1 Biomarkers for immunotherapy (PDF Format)

Session 1 Mechanisms of immune resistance (Video MP4 Format)

Session 1 Mechanisms of immune resistance (PDF Format)

Session 2 Immunotherapy for NSCLC (Video MP4 Format)

Session 2 Immunotherapy for NSCLC (PDF Format)

Session 2 Immunotherapy for SCLC and Mesothelioma (Video MP4 Format)

Session 2 Immunotherapy for SCLC and Mesothelioma (PDF Format)

Session 3 Immunotherapy for breast cancer (Video MP4 Format)

Session 3 Immunotherapy for breast cancer (PDF Format)

Session 3 Immunotherapy for gynaecological malignancies (Video MP4 Format)

Session 3 Immunotherapy for gynaecological malignancies (PDF Format)

Session 4 Immunotherapy for gastro-intestinal cancers (Video MP4 Format)

Session 4 Immunotherapy for gastro-intestinal cancers (PDF Format)

Session 5 Developments in adoptive T-cell transfer (Video MP4 Format)

Session 5 Developments in adoptive T-cell transfer (PDF Format)

Session 5 Developments in immune checkpoint inhibition (Video MP4 Format)

Session 5 Developments in immune checkpoint inhibition (PDF Format)

Session 6 Immunotherapy for liver and biliary cancer (Video MP4 Format)

Session 6 Immunotherapy for liver and biliary cancer (PDF Format)

Session 8 IrAEs and management of toxicities (Video MP4 Format)

Session 8 IrAEs and management of toxicities (PDF Format)

Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache (PDF Format)

Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer (PDF Format)

Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do (Video MP4 Format)

Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do (PDF Format)

Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab (PDF Format)

Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC (Video MP4 Format)

Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC (PDF Format)

Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome (Video MP4 Format)

Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome (PDF Format)

Welcome and Introduction (PDF Format)

Contact Us
Do you have any questions or need support? feel free to ask and we will help you with it